Category: Op-Ed

Joppe Nieuwenhuis, Innovation Scout at Rejuveron Life Sciences, discusses his views about the future of longevity and rejuvenation research and how it will merge with current medical frameworks and systems. About Rejuveron Rejuveron is a clinical-stage biotechnology company creating therapies to improve healthy aging. Its experienced drug discovery and development team applies a deep understanding...

Dr. Leon Peshkin talks us through a new open access research tool he has helped to develop and which is free for researchers to use now. If a drug increases lifespan in mice by 15%, should I take it? The idea of intervention testing in a model organism is simple: while keeping all conditions equal,...

The Program Director of the On Deck Longevity Biotech Fellowship gives us some examples of leaders and founders working on aging that came from "non-traditional" backgrounds. The myth that you need a biology degree to work in the longevity industry Many people are interested in getting involved in longevity but hesitate because they think a...

With so many health and disease outcomes connected to the biological aging processes, research into quantifying and tracking aging has surged in recent years due to the work of Steve Horvath, Morgan Levine, and others. Currently, epigenetic analysis of biological aging is thought to be the most comprehensive and accurate measurement of aging that is...

The life extension community has a number of long serving people in its ranks, and one of the longest-active of those in Russia is Mikhail Batin. His activities go way back to 2008 when the non-profit organization Science for Life Extension Foundation, which was first created with the mission to support scientific research to develop...

The good news is that the United States Senate has a Special Committee on Aging. The bad news is that it has little to do with the actual processes of aging and has not meaningfully furthered the research necessary to develop medical treatments for aging itself. Instead, the committee focuses its work on other issues...